Activation of CD8+ T cells occurs upon the engagement of the T cell receptor (TCR) complex that recognizes foreign or tumor antigens presented by MHC Class I molecules, in conjunction with co-receptors that enhance or diminish TCR signaling. Here, CD8A is linked to neoplasm.